Pharmaceutical Regulatory Affairs: Open Access

Regulatory Toxicologist, KGK Science Inc., One London Place, Suite 1440, 255 Queens Avenue, London, ON, Canada

Publications

• Review   
  Challenges in Regulating the North American Cannabisand Hemp-derived Product Market
  Author(s): Andrew Charrette, Najla Guthrie, James Akingbasote* and Corey J Hilmas
  
  Prior to the introduction of the Cannabis Act of 2018, recreational use and misuse of Cannabis was a public health concern in Canada. The United States (US) and other countries have met similar challenges in regulating the Cannabis and hemp markets under a patchwork of laws. Having been an illicit substance, the recreational Cannabis market has carried negative connotations without much consideration to well-established medical marijuana programs in North America. The intention of the Cannabis Act was to provide a comprehensive framework of regulations to protect public health and safety, reduce youth access, improve quality in the supply chain, and deter the illicit market and criminal activities. The market potential for hemp, which is defined as Cannabis containing 0.3% Δ-9-tetrahydrocannabinol (Δ.. Read More»
  DOI: 10.37421/2167-7689.2021.10.239

  Abstract HTML PDF